Literature DB >> 15731265

Characterization and intracellular localization of the Epstein-Barr virus protein BFLF2: interactions with BFRF1 and with the nuclear lamina.

Roberta Gonnella1, Antonella Farina, Roberta Santarelli, Salvatore Raffa, Regina Feederle, Roberto Bei, Marisa Granato, Andrea Modesti, Luigi Frati, Henri-Jacques Delecluse, Maria Rosaria Torrisi, Antonio Angeloni, Alberto Faggioni.   

Abstract

We have reported in the accompanying paper that the BFRF1 protein of Epstein-Barr virus (EBV) is important for efficient primary viral envelopment and egress (A. Farina, R. Feederle, S. Raffa, R. Gonnella, R. Santarelli, L. Frati, A. Angeloni, M. R. Torrisi, A. Faggioni, and H.-J. Delecluse, J. Virol. 79:3703-3712). Here we describe the characterization of the product of the EBV BFLF2 gene, which belongs to a family of conserved herpesviral genes which include the UL31 genes of herpes simplex virus and of pseudorabies virus and whose products are known to interact with UL34, the positional homolog of BFRF1. BFLF2 is an early transcript and is expressed in a variety of cell lines upon EBV lytic cycle activation. Western blotting of purified virion preparations showed that BFLF2 is a component of intracellular virions but is absent from mature extracellular virions. Coimmunoprecipitation experiments indicated that BFLF2 interacts with BFRF1, which was confirmed by immunofluorescence confocal microscopy showing that the two proteins colocalize on the nuclear membrane not only upon cotransfection in epithelial cells but also during viral replication. In cells carrying an EBV mutant with the BFRF1 gene deleted (293-BFRF1-KO cells) BFLF2 expression was low, and it was restored to wild-type levels upon treatment of the cells with the proteasome inhibitor MG132. Furthermore, recomplementing the 293-BFRF1-KO cells by BFRF1 transfection restored BFLF2 expression to the wild-type level. In addition, when expressed alone BFLF2 was localized diffusely inside the nucleus, whereas in the presence of BFRF1 the two proteins colocalized at the nuclear rim. Finally, 293 epithelial cells transfected with either protein or cotransfected were analyzed by electron microscopy to investigate potential alterations in the morphology of the nuclear membrane. The ultrastructural analysis revealed that (i) BFRF1 caused duplications of the nuclear membrane, similar to those reported to occur during the course of herpesviral replication, and (ii) while BFLF2 alone did not cause any apparent alteration, coexpression of the two proteins dramatically induced profound convolutions of the duplicated nuclear membrane. Both biochemical and morphological analysis showed association of the BFRF1-BFLF2 complex with a component of the nuclear lamina, lamin B. Taken together, these results and those of the accompanying paper (Farina et al., J. Virol. 79:3703-3712) indicate an important role of BFRF1 and BFLF2 in the early steps of EBV maturation at the nuclear membrane.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15731265      PMCID: PMC1075684          DOI: 10.1128/JVI.79.6.3713-3727.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  49 in total

1.  Sequence and structure-based prediction of eukaryotic protein phosphorylation sites.

Authors:  N Blom; S Gammeltoft; S Brunak
Journal:  J Mol Biol       Date:  1999-12-17       Impact factor: 5.469

2.  Phosphorylation of the Epstein-Barr virus (EBV) DNA polymerase processivity factor EA-D by the EBV-encoded protein kinase and effects of the L-riboside benzimidazole 1263W94.

Authors:  Edward Gershburg; Joseph S Pagano
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

3.  The UL34 gene product of herpes simplex virus type 2 is a tail-anchored type II membrane protein that is significant for virus envelopment.

Authors:  C Shiba; T Daikoku; F Goshima; H Takakuwa; Y Yamauchi; O Koiwai; Y Nishiyama
Journal:  J Gen Virol       Date:  2000-10       Impact factor: 3.891

4.  Intracellular localization of the UL31 protein of herpes simplex virus type 2.

Authors:  H Y Zhu; H Yamada; Y M Jiang; M Yamada; Y Nishiyama
Journal:  Arch Virol       Date:  1999       Impact factor: 2.574

Review 5.  Sorting out the nuclear envelope from the endoplasmic reticulum.

Authors:  Iain W Mattaj
Journal:  Nat Rev Mol Cell Biol       Date:  2004-01       Impact factor: 94.444

6.  The BamHI F region of the B95-8 Epstein-Barr virus genome.

Authors:  G S Hudson; T J Gibson; B G Barrell
Journal:  Virology       Date:  1985-11       Impact factor: 3.616

7.  Protein kinase C-beta II Is an apoptotic lamin kinase in polyomavirus-transformed, etoposide-treated pyF111 rat fibroblasts.

Authors:  Anna Chiarini; James F Whitfield; Ubaldo Armato; Ilaria Dal Pra
Journal:  J Biol Chem       Date:  2002-03-18       Impact factor: 5.157

8.  Intracellular transport and maturation pathway of human herpesvirus 6.

Authors:  M R Torrisi; M Gentile; G Cardinali; M Cirone; C Zompetta; L V Lotti; L Frati; A Faggioni
Journal:  Virology       Date:  1999-05-10       Impact factor: 3.616

9.  Herpes simplex virus type 1 primary envelopment: UL34 protein modification and the US3-UL34 catalytic relationship.

Authors:  Brent J Ryckman; Richard J Roller
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

10.  Microtubule-mediated transport of incoming herpes simplex virus 1 capsids to the nucleus.

Authors:  B Sodeik; M W Ebersold; A Helenius
Journal:  J Cell Biol       Date:  1997-03-10       Impact factor: 10.539

View more
  60 in total

Review 1.  Breach of the nuclear lamina during assembly of herpes simplex viruses.

Authors:  Lynda A Morrison; Gregory S DeLassus
Journal:  Nucleus       Date:  2011-07-01       Impact factor: 4.197

Review 2.  Role of tegument proteins in herpesvirus assembly and egress.

Authors:  Haitao Guo; Sheng Shen; Lili Wang; Hongyu Deng
Journal:  Protein Cell       Date:  2010-12-10       Impact factor: 14.870

3.  The Human Cytomegalovirus Transmembrane Protein pUL50 Induces Loss of VCP/p97 and Is Regulated by a Small Isoform of pUL50.

Authors:  Myoung Kyu Lee; Seokhwan Hyeon; Jin-Hyun Ahn
Journal:  J Virol       Date:  2020-06-16       Impact factor: 5.103

4.  Functional domains of murine cytomegalovirus nuclear egress protein M53/p38.

Authors:  Mark Lötzerich; Zsolt Ruzsics; Ulrich H Koszinowski
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

5.  Random screening for dominant-negative mutants of the cytomegalovirus nuclear egress protein M50.

Authors:  Brigitte Rupp; Zsolt Ruzsics; Christopher Buser; Barbara Adler; Paul Walther; Ulrich H Koszinowski
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

6.  Epstein-Barr virus-encoded protein kinase (BGLF4) is involved in production of infectious virus.

Authors:  Edward Gershburg; Salvatore Raffa; Maria Rosaria Torrisi; Joseph S Pagano
Journal:  J Virol       Date:  2007-03-14       Impact factor: 5.103

7.  Epstein-Barr virus and virus human protein interaction maps.

Authors:  Michael A Calderwood; Kavitha Venkatesan; Li Xing; Michael R Chase; Alexei Vazquez; Amy M Holthaus; Alexandra E Ewence; Ning Li; Tomoko Hirozane-Kishikawa; David E Hill; Marc Vidal; Elliott Kieff; Eric Johannsen
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-19       Impact factor: 11.205

8.  Murine gammaherpesvirus 68 ORF52 encodes a tegument protein required for virion morphogenesis in the cytoplasm.

Authors:  Eric Bortz; Lili Wang; Qingmei Jia; Ting-Ting Wu; Julian P Whitelegge; Hongyu Deng; Z Hong Zhou; Ren Sun
Journal:  J Virol       Date:  2007-07-18       Impact factor: 5.103

9.  Vesicle formation from the nuclear membrane is induced by coexpression of two conserved herpesvirus proteins.

Authors:  Barbara G Klupp; Harald Granzow; Walter Fuchs; Günther M Keil; Stefan Finke; Thomas C Mettenleiter
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-10       Impact factor: 11.205

10.  Epstein-Barr virus BGLF4 kinase induces disassembly of the nuclear lamina to facilitate virion production.

Authors:  Chung-Pei Lee; Yu-Hao Huang; Su-Fang Lin; Yao Chang; Yu-Hsin Chang; Kenzo Takada; Mei-Ru Chen
Journal:  J Virol       Date:  2008-09-24       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.